- Home
- HII vs BBIO Comparison
HII vs BBIO Comparison
Compare HII & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HII
- BBIO
- Stock Information
- Founded
- HII 1886
- BBIO 2015
- Country
- HII United States
- BBIO United States
- Employees
- HII N/A
- BBIO N/A
- Industry
- HII Marine Transportation
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- HII Industrials
- BBIO Health Care
- Exchange
- HII Nasdaq
- BBIO Nasdaq
- Market Cap
- HII 6.6B
- BBIO 6.7B
- IPO Year
- HII N/A
- BBIO 2019
- Fundamental
- Price
- HII $203.97
- BBIO $34.57
- Analyst Decision
- HII Hold
- BBIO Strong Buy
- Analyst Count
- HII 10
- BBIO 12
- Target Price
- HII $221.22
- BBIO $52.64
- AVG Volume (30 Days)
- HII 815.0K
- BBIO 2.7M
- Earning Date
- HII 05-01-2025
- BBIO 05-01-2025
- Dividend Yield
- HII 2.65%
- BBIO N/A
- EPS Growth
- HII N/A
- BBIO N/A
- EPS
- HII 13.96
- BBIO N/A
- Revenue
- HII $11,535,000,000.00
- BBIO $221,902,000.00
- Revenue This Year
- HII $4.59
- BBIO $12.42
- Revenue Next Year
- HII $4.26
- BBIO $123.19
- P/E Ratio
- HII $14.62
- BBIO N/A
- Revenue Growth
- HII 0.71
- BBIO 2285.27
- 52 Week Low
- HII $158.88
- BBIO $21.62
- 52 Week High
- HII $291.97
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- HII 60.01
- BBIO 51.35
- Support Level
- HII $200.75
- BBIO $35.77
- Resistance Level
- HII $207.64
- BBIO $37.06
- Average True Range (ATR)
- HII 5.38
- BBIO 1.40
- MACD
- HII 0.02
- BBIO 0.18
- Stochastic Oscillator
- HII 68.67
- BBIO 47.67
About HII Huntington Ingalls Industries Inc.
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun off of Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia and Columbia-class nuclear submarines. Huntington Ingalls shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's Mission Technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.